Enzyme immunoassay for the semi-quantitative determination of total (free and drug-bound) antibodies to Infliximab (Remicade®, Remsima®) in serum and plasma.
Due to the specific assay design this test measures the antibodies against Infliximab even in a high excess of the drug (up to 20-fold). Results are expressed in tAU (total arbitrary units).
Reference: IG-TA101
Barcode: 8682754930059
Legal Status: CE-Mark
Intended Use: This kit has been developed for the detection of total level of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-TA101 Download
Material Safety Data Sheet (MSDS) IG-TA101 Download
Quality Control Certificates
Remicade® is a trademark of Janssen Biotech, Inc./Merck & Co.
Remsima® is a trademark of CellTrion Inc.
